For instance, evidence of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) co-localization with aSyn aggregates in post-mortem PD tissue, which inhibits GAPDH activity and reduces the rate of downstream glycolytic steps [67,68]. The gene discussed is GAPDH; the disease is Parkinson disease.